Posted by Michael Wonder on 18 Oct 2023
FloBio receives FDA's breakthrough device designation for bleeding risk diagnostic test
17 October 2023 - Rapid detection of modern blood thinners could reduce preventable complications in US hospitals.
FloBio announced today that the US FDA has granted breakthrough device designation for its rapid bleeding risk diagnostic test.
